The safety of tenofovir (Viread) in pregnant women has not been demonstrated, but one study of tenofovir in pregnant monkeys found some evidence that infant size, weight and bone porosity were reduced in infants exposed to tenofovir. Circulating levels of insulin-like growth factor were also significantly lower in the exposed infants[1].